Disclosure Of Non-Current Assets Held For Sale And Discontinued Operations [Text Block]

Heidelberg Pharma AG - Filing #6821989

Concept 2020-12-01 to
2021-11-30
2019-12-01 to
2020-11-30
Disclosure of non-current assets held for sale and discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [abstract]
Disclosure of analysis of single amount of discontinued operations [line items]
Profit (loss) before tax
26.138.702 EUR
18.369.038 EUR
Revenue
1.749.829 EUR
8.487.938 EUR
Cash flows from continuing and discontinued operations [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities
26.612.520 EUR
17.892.611 EUR
Cash flows from (used in) investing activities [abstract]
Cash flows from (used in) investing activities
1.401.953 EUR
1.289.794 EUR
Cash flows from (used in) financing activities [abstract]
Cash flows from (used in) financing activities
29.169.662 EUR
14.290.458 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.